Biotech Networking and Intellikine CEO Troy Wilson

The San Diego Biotechnology Network is hosting Intellikine at this month’s biotech professional networking event, and Intellikine CEO Troy Wilson is scheduled to make a presentation about the company. Intellikine, which made news in July for raising a potential $51 million in venture capital funding, specializes in the development of innovative, small molecule drugs for the treatment of cancer, inflammation, and autoimmune diseases. More information and online registration is here.